Prothena Corporation plc To Report Fourth Quarter And Full Year 2013 Financial Results And Host Webcast And Conference Call On March 6

DUBLIN, Ireland, Feb. 18, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, announced today that it will report its fourth quarter and full year 2013 financial results on Thursday, March 6, 2014, after the close of the U.S. financial markets. The announcement will be followed by a conference call and live audio webcast at 4:30 p.m. ET.

Help employers find you! Check out all the jobs and post your resume.